| Literature DB >> 25546617 |
Urszula Piotrowska1, Marcin Sobczak2.
Abstract
Biodegradable or bioresorbable polymers are commonly used in various pharmaceutical fields (e.g., as drug delivery systems, therapeutic systems or macromolecular drug conjugates). Polyesters are an important class of polymers widely utilized in pharmacy due to their biodegradability and biocompatibility features. In recent years, there has been increased interest in enzyme-catalyzed ring-opening polymerization (e-ROP) of cyclic esters as an alternative method of preparation of biodegradable or bioresorbable polymers. Ionic liquids (ILs) have been presented as green solvents in enzymatic ring-opening polymerization. The activity, stability, selectivity of enzymes in ILs and the ability to catalyze polyester synthesis under these conditions are discussed. Overall, the review demonstrates that e-ROP of lactones or lactides could be an effective method for the synthesis of useful biomedical polymers.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25546617 PMCID: PMC6272625 DOI: 10.3390/molecules20010001
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Polymer-drug conjugate model proposed by Ringsdorf.
Examples of DDS obtained from polyesters.
| Polyesters | Therapeutic Agent | Ref. |
|---|---|---|
| poly(lactide- | Amphotericin B | [ |
| Ciprofloxacin | [ | |
| Cisplatin | [ | |
| Docetaxel | [ | |
| Doxorubicin | [ | |
| Paclitaxel | [ | |
| Rifampicin | [ | |
| r-hGH (recombinant human growth hormone) | [ | |
| polylactide (PLA) | Camptothecin | [ |
| Doxorubicin | [ | |
| 5-fluorouracil | [ | |
| poly(ε-caprolactone) (PCL) | Amphotericin B | [ |
| Ciprofloxacin | [ | |
| Citropin | [ | |
| Vancomycin | [ |
Scheme 1The synthesis of biodegradable polyesters used in DDS technology.
Origin of lipases commonly used in the e-ROP of cyclic esters.
| Origin of Lipases | Ref. |
|---|---|
| [ | |
| [ | |
| [ | |
| [ | |
| [ | |
| Porcine pancreatic | [ |
| [ | |
| [ | |
| [ |
Ionic liquids discussed in this review.
| ILs | Abbreviation |
|---|---|
| 1-Butyl-3-methylimidazolium tetrafluoroborate | [bmim][BF4] |
| 1-Butyl-3-methylimidazolium bis((trifluoromethyl)-sulfonyl)imide | [bmim][NTf2] |
| 1-Butyl-3-methylimidazolium hexafluorophosphate | [bmim][PF6] |
| 1-Butyl-3-methylimidazolium trifluoromethanesulfonate | [bmim][OTf] |
| 1-Ethyl-3-methylimidazolium tetrafluoroborate | [emim][BF4] |
| 1-Hexyl-3-methylimidazolium hexafluorophosphate | [hmim][PF6] |
| 1,4-bis(3-Hexylimidazolium-1-yl)butane bishexafluorophosphate | [C4(C6Im)2][PF6] |
| 1-Dodecyl-3-methylimidazolium bis((trifluoromethyl)-sulfonyl)imide | [C12MIm][NTf2] |
| 1-Dodecyl-3-methylimidazolium hexafluorophosphate | [C12MIm][PF6] |
Figure 22,6-Diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate (Reichardt’s dye).
Physicochemical properties of ILs commonly used in biocatalysis.
| ILs | Polarity ETN (RT) | Melting Point (°C) | Viscosity in 20 °C (cP) | Density (g·cm−3) | Conductivity (S·m−1) | Water Solubility (WS) (%w/v) | |
|---|---|---|---|---|---|---|---|
| [bmim][BF4] | 0.680 | 226 | −82 | 233 | 1.17 | 0.17 | 100 |
| [bmim[Tf2N] | 0.645 | 419 | −4 | 52 | 1.43 | 0.39 | 1.40 |
| [bmim][PF6] | 0.676 | 284 | −8 | 312 | 1.362 | 0.14 | 0.13 |
Ring opening enzymatic polymerization and copolymerization of cyclic esters in ionic liquids.
| Monomer | ILs | Purity of ILs (%) | Enzyme | Temp. (°C) | Time (h) | Mn (Da) | Y/C (%) | Ref. | |
|---|---|---|---|---|---|---|---|---|---|
| [bmim][BF4] | - | CA | 60 | 168 | 4200 | 2.7 | 97C | [ | |
| [bmim][BF4] | ≥99 | CA | 60 | 24 | 12,700 | 1.8 | 35Y | [ | |
| [bmim][BF4] | - | YLL | 100 | 16 | 1758 | 1.7 | - | [ | |
| [bmim][BF4] | - | YLL | 150 | 6 | 3092 | 2.5 | - | [ | |
| [bmim][PF6] | - | CA | 60 | 72 | 540 | 4.2 | 62C | [ | |
| [bmim][PF6] | ≥99 | CA | 60 | 24 | 12,200 | 1.7 | 30Y | [ | |
| CL | [bmim][NTf2] | ≥99 | CA | 60 | 24 | 10,500 | 2.1 | 44Y | [ |
| [bmim][NTf2] | ≥97 | CA | 90 | 24 | 8100 | - | 85Y | [ | |
| [C4(C6Im)2][PF6] | - | CA | 90 | 48 | 26,200 | - | 62Y | [ | |
| [C12MIm][PF6] | - | CA | 90 | 48 | 11,700 | - | 37Y | [ | |
| [C12MIm][NTf2] | - | CA/ILs | 60 | 48 | 35,600 | - | 62Y | [ | |
| [C12MIm][NTf2] | - | CA | 60 | 48 | 20,300 | - | 54Y | [ | |
| LLA | [bmim][BF4] | ≥99 | CA | 110 | 24 | 54,600 | 1.25 | 24.3Y96.2C | [ |
| [bmim][PF6] | ≥99 | CA | 65 | 264 | 581 | 1.2 | 29.5Y | [ | |
| [bmim][PF6] | - | CA | 90 | 120 | 19,600 | 1.2 | - | [ | |
| [bmim][PF6] | ≥99 | CA | 120 | 24 | 3900 | 1.19 | 0.1Y90.4C | [ | |
| [hmim][PF6] | ≥97 | CA | 90 | 168 | 37,800 | 1.3 | 63.2Y | [ | |
| [hmim][PF6] | ≥97 | CA | 65 | 120 | 1700 | 1.3 | 16.5Y | [ | |
| [bmim][NTf2] | ≥99 | CA | 120 | 24 | 50,100 | 1.42 | 10.5Y | [ | |
| DO | [bmim][PF6] | ≥99 | CA/ILs | 70 | 18 | 182,100 | - | - | [ |
| [bmim][PF6] | ≥99 | CA | 70 | 24 | 27,700 | - | - | [ | |
| GA | [bmim][PF6] | ≥99 | CA | 65 | 96 | - | - | - | [ |
| LLA:GA (1:3) | [hmim][PF6] | ≥97 | CA | 65 | 120 | 3500 | 1.3 | 40.2Y | [ |
| [bmim][PF6] | ≥99 | CA | 65 | 96 | 2400 | 1.1 | 36.7Y | [ | |
| LLA:GA (3:1) | [bmim][PF6] | ≥99 | CA | 90 | 144 | 18,500 | 1.1 | - | [ |
CL: ε-caprolactone; LLA: l-lactide; DO: (1,4-dioxane)-2-one; GA: glycolide; LLA:GA: molar ratio of l-lactide to glycolide; CA: lipase from Candida antarctica; YLL: lipase from Yarrowia lipolytica; CA/ILs: lipase from Candida antarctica coated with ionic liquids; PDI: polydispersity index; Y: yield; C: conversion.